A large analysis found that escitalopram is the most effective antidepressant for preventing relapse in recovering depression patients, outperforming others like agomelatine and duloxetine. This research...
U.S. and Zambian officials signed a health agreement on October 8, shifting from a donor-recipient model to a partnership emphasizing Zambian leadership. This change occurs amid a chaotic overhaul of U.S....
The rise in popularity of GLP-1 weight-loss drugs is raising concerns among mental health experts, as they may worsen eating disorders, which have already increased by 71% globally since 1990. Clinicians warn...